Christopher David - May 31, 2023 Form 4 Insider Report for Novo Integrated Sciences, Inc. (NVOS)

Role: COO & President, Director
Signature: /s/ Christopher David
Stock symbol: NVOS
Transactions as of: May 31, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/2/2023, 04:05 PM
Next filing: Sep 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NVOS	Class A Common Stock						82K	May 31, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVOS	Stock Option (right to buy)	Award	$0	+2M		$0.00	2M	May 31, 2023	Common Stock	2M	$0.13	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant, by the issuer's Board of Directors, of an option to purchase 2,000,000 shares of the issuer's common stock at an exercise price of $0.132 per share. The option was fully vested and exercisable on the date of grant and expires on May 31, 2029.